NYSE:DGXHealthcare
Quest Diagnostics (DGX) 9% Net Margin Resurgence Challenges Long Term Earnings Decline Narrative
Quest Diagnostics FY 2025 earnings in focus
Quest Diagnostics (DGX) has put its FY 2025 numbers on the table with Q4 revenue of US$2.8 billion and basic EPS of US$2.21, backed by net income of US$245 million for the quarter and US$988 million over the trailing twelve months. Over recent periods, revenue has moved from US$2.6 billion in Q4 2024 to US$2.8 billion in Q4 2025, while quarterly basic EPS has shifted from US$1.98 to US$2.21. This gives investors a clearer view of how the top line...